Login
$ZPTA
$0.08 +$0.00 (0.0%) Close

$ZPTA SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Golestani Clark, Director

Bought 40,000 shares ($30K) · Received 25,000 shares as a grant or award

09 Nov 2026 10-Q
20 Oct 2026 8-K: Regulation FD Disclosure

New appointments of global quantum experts Shor, Paler, Devitt and Izmaylov further validate Zapata’s approach to quantum software

13 Oct 2026 8-K: Submission of Matters to a Vote of Security Holders

On October 9, 2026, Zapata Quantum, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). At the 2026 Annual Meeting, the Company’s stockholders voted (i) to elect three directors to hold office f...

06 Oct 2026 8-K: Regulation FD Disclosure

Effort builds on prior collaboration to translate high-value use cases into practical applications running on IBM quantum computers

23 Sep 2026 8-K: Regulation FD Disclosure

Drawing on Zapata’s pioneering quantum software expertise, the platform helps enterprises

15 Sep 2026 8-K: Regulation FD Disclosure

Recognition reflects a successful ground-up restructuring that positions the

14 Sep 2026 Proxy statement: annual meeting on October 9, 2026

say-on-pay vote

04 Sep 2026 PRELIMINARY PROXY STATEMENT
14 Aug 2026 FORM 424B3
14 Aug 2026 FORM 10-Q FOR JUN 2026
12 Aug 2026 8-K: Regulation FD Disclosure

The partnership combines QuEra's fault-tolerant hardware roadmap with Zapata's application intelligence expertise to bridge the quantum applications gap

11 Aug 2026 FORM 424B3
10 Aug 2026 EFFECT
05 Aug 2026 8-K: Entry into a Material Definitive Agreement

On July 30, 2026, Zapata Quantum, Inc. (the “Company”) entered into an Exclusive Broker-Dealer and Leak-Out Management Agreement (the “B/D Agreement”) with Chardan Capital Markets LLC (the “B/D”), pursuant to which the B/D agreed to act ...

09 Jul 2026 8-K: Regulation FD Disclosure

The Software Platform to Unlock Quantumʼs Potential July 2026

09 Jul 2026 AMENDMENT NO 1
07 Jul 2026 8-K: Unregistered Sales of Equity Securities

CEO Sumit Kapur will discuss highlights including the Company's NVIDIA collaboration and quantum cancer research recognized as a Nature Biotechnology Top 10

05 Jun 2026 FORM S-1
15 May 2026 FORM 10-Q

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support